Hls Therapeutics Inc (HLS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2004 | 06-2004 | 03-2004 | 12-2003 | 09-2003 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,777 | 3,898 | 5,470 | 3,030 | N/A |
| Marketable Securities | N/A | N/A | N/A | 153 | N/A |
| Receivables | 10,182 | 9,293 | 9,117 | 10,082 | 13,206 |
| Inventories | 109 | 86 | 184 | 200 | 301 |
| TOTAL | $15,900 | $16,441 | $17,533 | $15,540 | $15,461 |
| Non-Current Assets | |||||
| PPE Net | 5,558 | 6,200 | 6,785 | 7,311 | 7,261 |
| Other Non-Current Assets | 18,312 | 18,040 | 18,304 | 18,639 | 19,724 |
| TOTAL | $23,870 | $24,239 | $25,090 | $25,951 | $26,985 |
| Total Assets | $39,770 | $40,681 | $42,623 | $41,491 | $42,446 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 3,011 | 2,886 | 3,048 | 3,043 | 2,758 |
| Accounts payable and accrued liabilities | 4,162 | 4,737 | 5,956 | 4,667 | 5,109 |
| TOTAL | $7,173 | $7,623 | $9,003 | $7,710 | $7,867 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 4,894 | 5,765 | 0 | 0 | 7,773 |
| TOTAL | $4,894 | $5,765 | $6,322 | $7,107 | $8,051 |
| Total Liabilities | $12,067 | $13,388 | $15,325 | $14,817 | $15,918 |
| Shareholders' Equity | |||||
| Retained earnings | -952 | -806 | -1,366 | -2,196 | -1,536 |
| Other shareholders' equity | -3,367 | -2,195 | -2,136 | -2,273 | -1,729 |
| TOTAL | $27,703 | $27,292 | $27,298 | $26,674 | $26,528 |
| Total Liabilities And Equity | $39,770 | $40,681 | $42,623 | $41,491 | $42,446 |